December 12, 2023
CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment
PRESS RELEASE CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment LONDON, United…
May 15, 2023
CHARM Therapeutics Receives Investment for Deep Learning-enabled Drug Discovery Research from NVIDIA
PRESS RELEASE Investment enables CHARM to continue to fund its rapidly growing organization while harnessing…
March 20, 2023
CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs
PRESS RELEASE Collaboration will leverage CHARM’s DragonFold deep learning platform to identify compounds against targets…
January 4, 2023
CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability
PRESS RELEASE CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and…